-
Tobias Feuchtinger, Peter Bader, Marion Subklewe, Maike Breidenbach, Semjon Willier, Markus Metzler, Nicola Gokbuget, Julia Hauer, Fabian Muller, Paul-Gerhardt Schlegel, Michael Fruehwald, Christoph Schmid, Anja Troeger, Claudia Baldus, Roland Meisel, Annette Kunkele, Max Topp, Jean-Pierre Bourquin, Gunnar Cario, Arend von Stackelberg, Christina Peters: Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukaemia in children and young adults. Haematologica 2024, in press
-
Marianne Unterfrauner, Hazal Aslan, Anne Hartz, Sophia Bohlscheid, Tobias Baudrexler, Xiaojia Feng, Elias Rackl, Lin Li, Andreas Rank, Giuliano Filippini Velázquez, Christoph Schmid, Jörg Schmohl, Peter Bojko, Helga Schmetzer *: GM-CSF Combined with PGE-1 Create Dendritic Cells of Leukemic Origin (DCleu) from AML Patients’ Whole Blood and Whole Bone Marrow that Mediate Antileukemic Processes after Mixed Lymphocyte Culture. Int J Mol Sci. 2023 Dec 13;24(24):17436. doi: 10.3390/ijms242417436Bonig H, Verbeek M, Herhaus P, Braitssch K, Beutel G, Christoph Schmid, Müller N, Bug G, Döring M, von Stackelberg A, Tischer J, Ayuk F, Wulf G, Holtick U, Pfeffermann LM, Jahrsdörfer B, Schrezenmeier H, Kuci S, Kuci Z, Zens A, Tribanek M, Zeiser R, Huenecke S, Bader P. Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease. J Transl Med. 2023 Nov 21;21(1):837. doi: 10.1186/s12967-023-04731-1
-
Bonig H, Verbeek M, Herhaus P, Braitssch K, Beutel G, Christoph Schmid, Müller N, Bug G, Döring M, von Stackelberg A, Tischer J, Ayuk F, Wulf G, Holtick U, Pfeffermann LM, Jahrsdörfer B, Schrezenmeier H, Kuci S, Kuci Z, Zens A, Tribanek M, Zeiser R, Huenecke S, Bader P. Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease. J Transl Med. 2023 Nov 21;21(1):837. doi: 10.1186/s12967-023-04731-1
-
Dintner S, Schmutz M, Sommer S, Langer A, Hirschbühl K, Claus R, Christoph Schmid, Trepel M, Märkl B. NGS-based molecular genetics of leukemia-a powerful and decentralized approach Pathologie (Heidelb). 2023 Nov 17. doi: 10.1007/s00292-023-01268-4. Online ahead of print
-
Kröger N, Wulf G, Hegenbart U, Burchert A, Stelljes M, Gagelmann N, Brecht A, Kaufmann M, Müller L, Ganser A, Wolf D, Bethge W, Bornhäuser M, Kiehl M, Wagner EM, Christoph Schmid, Reinhardt HC, Kobbe G, Salwender H, Heinicke T, Kropff M, Heinzelmann M, Ayuk F, Trümper L, Neubauer A, Völp A, Kluychnikov E, Schönland S, Wolschke C. Autologous-allogeneic versus autologous tandem stemm cell transplantation and maintenance therapie with thalidomide for multiple myeloma patients over 60 years age: a prospective phase II study. Haematologica. 2023 Nov 9. doi: 10.3324/haematol.2023.282920. Online ahead of print
-
Sauerer T, Velázquez GF, Christoph Schmid Relapse of Acute Myeloid Leukemia after allogeneic stem cell transplantation: Immune escape mechanisms and current implications for therapy molecular cancer accepted, Mol Cancer. 2023 Nov 11;22(1):180. doi: 10.1186/s12943-023-01889-6
-
Gerbitz A, Gary R, Aigner M, Moosmann A, Kremer A, Christoph Schmid, Hirschbuehl K, Wagner E, Hauptrock B, Teschner D, Roesler W, Spriewald B, Tischer J, Moi S, Balzer H, Schaffer S, Bausenwein J, Wagner A, Schmidt F, Brestrich J, Ullrich B, Maas S, Herold S, Strobel J, Zimmermann R, Weisbach V, Hansmann L, Lammoglia-Cobo F, Remberger M, Stelljes M, Ayuk F, Zeiser R, Mackensen A. Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study. Front Immunol. 2023 Oct 30;14:1251593. doi: 10.3389/fimmu.2023.1251593. eCollection 2023
-
Baudrexler T, Boeselt T, Li L, Bohlscheid S, Boas U, Christoph Schmid, Rank A, Schmohl J, Koczulla R, Schmetzer HM. Volatile Phases Derived from Serum, DC, or MLC Culture Supernatants to Deduce a VOC-Based Diagnostic Profiling Strategy for Leukemic Diseases Biomolecules. 2023 Jun 14;13(6):989. doi: 10.3390/biom13060989
-
Kharfan-Dabaja MA, Labopin M, Ayala E, Bazarbachi A, Blaise D, Vydra J, Bramanti S, Itälä-Remes M, Christoph Schmid, Busca A, Forcade E, Rabitsch W, Zecca M, Kröger N, Bulabois CE, Grillo G, Rambaldi A, Fanin R, Zallio F, Di Renzo N, Koc Y, Novis Y, McDonald A, Herrera Arroyo C, Sanz J, Nagler A, Ciceri F, Mohty Significance of Degree of HLA Disparity Using T-cell Replete Peripheral Blood Stem Cells From Haploidentical Donors With Posttransplantation Cyclophosphamide in AML in First Complete Hematologic Remission: A Study of the Acute Leukemia Working Party of the EBMT M. Hemasphere. 2023 Jun 27;7(7):e920. doi: 10.1097/HS9.0000000000000920. eCollection 2023 Jul
-
Nagler A, Labopin M, Blaise D, Raiola AM, Corral LL, Bramanti S, Sica S, Kwon M, Koc Y, Pavlu J, Kulagin A, Busca A, Rodríguez AB, Reményi P, Christoph Schmid, Brissot E, Sanz J, Bazarbachi A, Giebel S, Ciceri F, Mohty M. Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT J Hematol Oncol. 2023 May 29;16(1):58. doi: 10.1186/s13045-023-01450-4v
-
Hirschbühl K, Labopin M, Polge E, Blaise D, Bourhis JH, Socié G, Forcade E, Yakoub-Agha I, Labussière-Wallet H, Bethge W, Chevallier P, Bonnet S, Stelljes M, Spyridonidis A, Peric Z, Brissot E, Savani B, Giebel S, Christoph Schmid*, Ciceri F, Nagler A, Mohty M. Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years-a registry-based study by the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplant. 2023 May 5. doi: 10.1038/s41409-023-01966-w. Online ahead of print. *corresponding author
- Filippini Velázquez G, Labopin M, Tischer J, Raiola AM, Angelucci E, Kulagin AD, Galieni P, Bermúdez A, Bulabois CE, Kröger N, Díez-Martín JL, Kwon M, Nagler A, Christoph Schmid*, Ciceri F, Mohty M. Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia-a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2023 May 9. doi: 10.1038/s41409-023-01985-7. Online ahead of print. *corresponding author
- Martin Bornhäuser, Christoph Schliemann, Johannes Schetelig, Christoph Röllig, Michael Kramer, Bertram Glass, Uwe Platzbecker, Andreas Burchert, Mathias Hänel, Lutz P Müller, Stefan Klein, Gesine Bug, Dietrich Beelen, Wolf Rösler, Kerstin Schäfer-Eckart, Christoph Schmid, Edgar Jost, Georg Lenz, Johanna Tischer, Karsten Spiekermann, Markus Pfirrmann, Hubert Serve, Friedrich Stölzel, Nael Alakel, Jan Moritz Middeke, Christian Thiede, Gerhard Ehninger, Wolfgang E Berdel, Matthias Stelljes „Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical Trial“ JAMA Oncol. 2023 Apr 1;9(4):519-526. doi: 10.1001/jamaoncol.2022.7605. (available on 2024-02-09)
- Phillip Löhr, Stefan Schiele, Tim Tobias Arndt, Stefanie Grützner, Rainer Claus, Christoph Römmele, Gernot Müller, Christoph Schmid, Kevin M Dennehy, Andreas Rank „Impact of age and gender on lymphocyte subset counts in patients with COVID-19” Cytometry A. 2023 Feb;103(2):127-135. doi: 10.1002/cyto.a.24470. Epub 2021 Jun 23
- Peter-Martin Bruch, Sascha Dietrich, Herve Finel, Ariane Boumendil, Hildegard Greinix, Thomas Heinicke, Wolfgang Bethge, Dietrich Beelen, Christoph Schmid, Hans Martin, Luca Castagna, Christof Scheid, Kerstin Schäfer-Eckart, Jörg Bittenbring, Jürgen Finke, Henrik Sengeloev, Mael Heiblig, Jan Cornelissen, Patrice Chevallier, Mohamad Mohty, Stephen Robinson, Silvia Montoto, Peter Dreger „Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters“ Leukemia. 2023 Feb;37(2):465-472. doi: 10.1038/s41375-022-01782-z. Epub 2022 Dec 22.
- Alexandros Spyridonidis, Myriam Labopin, Bipin Savani, Sebastian Giebel, Gesine Bug, Stefan Schönland, Nicolaus Kröger, Matthias Stelljes, Thomas Schroeder, Andrew McDonald, Igor-Wolfgang Blau, Martin Bornhäuser, Montse Rovira, Wolfgang Bethge, Andreas Neubauer, Arnold Ganser, Jean Henri Bourhis, Matthias Edinger, Bruno Lioure, Gerald Wulf, Kerstin Schäfer-Eckart, Mutlu Arat, Zinaida Peric, Christoph Schmid, Ali Bazarbachi, Fabio Ciceri, Arnon Nagler, Mohamad Mohty „Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT” Hemasphere. 2023 Jan 9;7(1):e812 doi: 10.1097/HS9.0000000000000812. eCollection 2023 Jan.
- Sabine Kayser, David Martínez-Cuadrón, Maher Hanoun, Friedrich Stölzel, Cristina Gil, H Christian Reinhardt, Eliana Aguiar, Kerstin Schäfer-Eckart, Juan Miguel Bergua Burgues, Björn Steffen, Teresa Bernal, Stefan W Krause, Rosalía Riaza, Christoph Schliemann, Jose Cervera, Martin Kaufmann, Laura Torres-Miñana, Mathias Hänel, Evelyn Acuña-Cruz, Edgar Jost, Jesus Lorenzo Algarra, Martina Crysandt, Lars Fransecky, Javier Cornago-Navascues, Sabrina Kraus, Joaquin Martinez-Lopez, Hermann Einsele, Dirk Niemann, Andreas Neubauer, Ruth Seggewiß-Bernhardt, Sebastian Scholl, Stefan A Klein, Christoph Schmid, Markus Schaich, Martin Schmidt-Hieber, Sven Zukunft, Anthony D Ho, Uwe Platzbecker, Claudia D Baldus, Carsten Müller-Tidow, Christian Thiede, Martin Bornhäuser, Hubert Serve, Mark Levis, Pau Montesinos, Christoph Röllig, Richard F Schlenk „Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4” Haematologica. 2023 Jan 1;108(1):34-41. doi: 10.3324/haematol.2022.281137.
- Elias Rackl, Lin Li, Lara Kristina Klauer, Selda Ugur, Elena Pepeldjiyska, Corinna L Seidel, Carina Gunsilius, Melanie Weinmann, Fatemeh Doraneh-Gard, Nina Reiter, Caroline Plett, Daniel Christoph Amberger, Peter Bojko, Doris Kraemer, Jörg Schmohl, Andreas Rank, Christoph Schmid, Helga Maria Schmetzer „Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes” Int J Mol Sci. 2022 Dec 27;24(1):463 doi: 10.3390/ijms24010463.
- Arnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, Myriam Labopin, Thomas Valerius, Peter Dreger, Nicolaus Kröger, Hans Christian Reinhardt, Jürgen Finke, Georg-Nikolaus Franke, Fabio Ciceri, Mareike Verbeek, Igor Wolfgang Blau, Martin Bornhäuser, Alexandros Spyridonidis, Gesine Bug, Ali Bazarbachi, Christoph Schmid, Ibrahim Yakoub-Agha, Bipin N Savani, Mohamad Mohty „Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia“ Bone Marrow Transplant . 2022 Dec;57(12):1854. doi: 10.1038/s41409-022-01834-z.
- Caroline Plett, Lara Kristina Klauer, Daniel Christoph Amberger, Selda Ugur, Alexander Rabe, Zuzana Fischer, Diana Deen, Annika Hirn-Lopez, Carina Gunsilius, Jan-Ole Werner, Jörg Schmohl, Doris Krämer, Andreas Rank, Christoph Schmid, Helga Maria Schmetzer „Immunomodulatory kits generating leukaemia derived dendritic cells do not induce blast proliferation ex vivo: IPO-38 as a novel marker to quantify proliferating blasts in acute myeloid leukaemia” Clin Immunol . 2022 Sep;242:109083. doi:10.1016/j.clim.2022.109083. Epub 2022 Jul 28.
- Elena Pepeldjiyska, Lin Li, Jincheng Gao, Corinna L Seidel, Christian Blasi, Erdem Özkaya, Jörg Schmohl, Doris Kraemer, Christoph Schmid, Andreas Rank, Helga Maria Schmetzer „Leukemia derived dendritic cell (DCleu) mediated immune response goes along with reduced (leukemia-specific) regulatory T-cells” Immunobiology. 2022 Jul;227(4):152237. doi: 10.1016/j.imbio.2022.152237. Epub 2022 Jun 11.
- Arnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, Myriam Labopin, Thomas Valerius, Peter Dreger, Nicolaus Kröger, Hans Christian Reinhardt, Jürgen Finke, Georg-Nikolaus Franke, Fabio Ciceri, Mareike Verbeek, Igor Wolfgang Blau, Martin Bornhäuser, Alexandros Spyridonidis, Gesine Bug, Ali Bazarbachi, Christoph Schmid, Ibrahim Yakoub-Agha, Bipin N Savani, Mohamad Mohty „Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia“ Bone Marrow Transplant. 2022 Jul;57(7):1116-1123. doi: 10.1038/s41409-022-01693-8. Epub 2022 Apr 30.
- G Filippini Velázquez, S Schiele, M Gerken, S Neumaier, C Hackl, P Mayr, M Klinkhammer-Schalke, G Illerhaus, H J Schlitt, M Anthuber, T Kröncke, H Messmann, B Märkl, C Schmid, M Trepel, G Müller, R Claus, B Hackanson “Predictive preoperative clinical score for patients with liver-only oligometastatic colorectal cancer” ESMO Open. 2022 Jun;7(3):100470. doi: 10.1016/j.esmoop.2022.100470
- Lara Kristina Klauer, Olga Schutti, Selda Ugur, Fatemeh Doraneh-Gard, Daniel Christoph Amberger, Nicole Rogers, Doris Krämer, Andreas Rank, Christoph Schmid, Britta Eiz-Vesper, Helga Maria Schmetzer Interferon Gamma Secretion of Adaptive and Innate Immune Cells as a Parameter to Describe Leukaemia-Derived Dendritic-Cell-Mediated Immune Responses in Acute Myeloid Leukaemia in vitro Transfus Med Hemother. 2021 Jul 7;49(1):44-61. doi: 10.1159/000516886. eCollection 2022 Feb. doi: 10.1159/000516886
- Christoph Schwepcke, Lara Kristina Klauer, Diana Deen, Daniel Christoph Amberger, Zuzana Fischer, Fatemeh Doraneh-Gard, Carina Gunsilius, Annika Hirn-Lopez, Tanja Kroell, Johanna Tischer, Melanie Weinmann, Jan-Ole Werner, Andreas Rank, Christoph Schmid, Helga Maria Schmetzer Generation of Leukaemia-Derived Dendritic Cells (DCleu) to Improve Anti-Leukaemic Activity in AML: Selection of the Most Efficient Response Modifier Combinations Int J Mol Sci. 2022 Jul 28;23(15):8333.
- Eduardo Rodríguez-Arbolí 1 ✉, Myriam Labopin 2 , Matthias Eder3 , Arne Brecht 4 , Igor Wolfgang Blau5 , Anne Huynh 6 , Edouard Forcade 7 , Johanna Tischer 8 , Wolfgang Bethge 9 , Sergey Bondarenko 10 , Mareike Verbeek 11 , Claude Eric Bulabois12 , Hermann Einsele 13 , Friedrich Stölzel 14 , Bipin Savani15 , Alexandros Spyridonidis 16 , Ali Bazarbachi 17 , Sebastian Giebel 18 , Eolia Brissot 2, , Christoph Schmid 19, Arnon Nagler 20 and Mohamad Mohty 2 „Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysis“ Bone Marrow Transplantation (2022) 57:934–941;
- Patrick Mayr 1 , Tatiana Grünewald 1 , Giuliano Filippini Velazquez 1 , Andreas Rank 1 , Christoph Schmid 1 , Manuela Harloff 2 , Bruno Märkl 2 , Martin Trepel 1 , Klaus Hirschbühl 1 , Tim Pfeiffer, 1 Rainer Claus “Transfusion-refractory pancytopenia with MDS-like morphologic alterations of the bone marrow in a 29-year old man: A mimicry manifestation caused by scurvy”. Br J Haematol 2022 Jun;197(5):627-630. doi: 10.1111/bjh.18064.
- Bazarbachi A, Labopin M, Aljurf M, Niittyvuopio R, Balsat M, Blaise D, Yakoub-Agha I, Grassi A, Reinhardt HC, Lenhoff S, Jindra P, Passweg J, Abou Dalle I, Stadler M, Lioure B, Ceballos P, Brissot E, Giebel S, Nagler A, Schmid C, Mohty M. “20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation.” Clin Cancer Res. 2022 Jan 12.
- Freudenreich M, Tischer J, Kroell T, Kremser A, Dreyßig J, Beibl C, Liepert A, Kolb HJ, Schmid C, Schmetzer H., In Vitro Generated Dendritic Cells of Leukemic Origin Predict Response to Allogeneic Stem Cell Transplantation in Patients With AML and MDS J Immunother. 2022 Feb-Mar 01;45(2):104-118. doi: 10.1097/CJI.0000000000000404.
- Schmid C, Labopin M, Schaap N, Veelken H, Brecht A, Stadler M, Finke J, Baron F, Collin M, Bug G, Ljungman P, Blaise D, Tischer J, Bloor A, Kulagin A, Giebel S, Gorin NC, Esteve J, Ciceri F, Savani B, Nagler A, Mohty M. Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia Bone Marrow Transplant. 2022 Feb;57(2):215-223.
- Rank A, Tzortzini A, Kling E, Schmid C, Claus R, Löll E, Burger R, Römmele C, Dhillon C, Müller K, Girl P, Hoffmann R, Grützner S, Dennehy KM. One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms. J Clin Med. 2021 Jul 27;10(15):3305. doi: 10.3390/jcm10153305.
- Esteve J, Giebel S, Labopin M, Czerw T, Wu D, Volin L, Socié G, Yakoub-Agha, I, Maertens J, Cornelissen JJ, Pigneux A, Shimoni A, Schwerdtfeger R, Labussière-Wallet H, Russell N, Schattenberg A, Chevallier P, Koza V, Foà R, Schmid C, Peric Z, Mohty M, Nagler A. Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMT. Leukemia. 2021 Aug;35(8):2232-2242.
- Brissot E, Labopin M, Baron F, Bazarbachi A, Bug G, Ciceri F, Esteve J, Giebel S, Gilleece MH, Gorin NC, Lanza F, Peric Z, Ruggeri A, Sanz J, Savani BN, Schmid C, Shouval R, Spyridonidis A, Versluis J, Nagler A, Mohty M. Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2021 Mar;56(3):532-535.
- Shouval R, Fein JA, Labopin M, Cho C, Bazarbachi A, Baron F, Bug G, Ciceri F, Corbacioglu S, Galimard JE, Giebel S, Gilleece MH, Giralt S, Jakubowski A, Montoto S, O'Reilly RJ, Papadopoulos EB, Peric Z, Ruggeri A, Sanz J, Sauter CS, Savani BN, Schmid C, Spyridonidis A, Tamari R, Versluis J, Yakoub-Agha I, Perales MA, Mohty M, Nagler A. Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry. Lancet Haematol. 2021 Mar;8(3):e205-e215. doi:10.1016/S2352-3026(20)30394-X. Erratum in: Lancet Haematol. 2021 Jun;8(6):e393.
- Merle M, Fischbacher D, Liepert A, Grabrucker C, Kroell T, Kremser A, Dreyssig J, Freudenreich M, Schuster F, Borkhardt A, Kraemer D, Koehne CH, Kolb HJ, Schmid C, Schmetzer HM. „Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts correlations of released chemokines with antileukemic T-cell reactions. Immunobiology. 2021 May;226(3):152088. doi: 10.1016/j.imbio.2021.152088. Epub 2021 Mar 20.
- Kharfan-Dabaja MA, Labopin M, Bazarbachi A, Ciceri F, Finke J, Bruno B, Bornhäuser M, Gedde-Dahl T, Labussière-Wallet H, Niittyvuopio R, Valerius T, Angelucci E, Brecht A, Caballero D, Kuball J, Potter V, Schmid C, Tischer J, Zuckerman T, Benedetti F, Blaise D, Diez-Martin JL, Sanz J, Ruggeri A, Brissot E, Savani BN, Giebel S, Nagler A, Mohty M. Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT. Bone Marrow Transplant. 2021 Sep;56(9):2194-2202. doi: 10.1038/s41409-021-01317-7. Epub 2021 Apr 30.
- Schuler E, Wagner-Drouet EM, Ajib S, Bug G, Crysandt M, Dressler S, Hausmann A, Heidenreich D, Hirschbühl K, Hoepting M, Jost E, Kaivers J, Klein S, Koldehoff M, Kordelas L, Kriege O, Müller LP, Rautenberg C, Schaffrath J, Schmid C, Wolff D, Haas R, Bornhäuser M, Schroeder T, Kobbe G; German Cooperative Transplant Study Group. Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group. Ann Hematol. 2021 Apr;100(4):959-968. doi: 10.1007/s00277-020-04321-x. Epub 2020 Nov 16. Erratum in: Ann Hematol. 2021 Aug;100(8):2141-2142.
- Nagler A, Baron F, Labopin M, Polge E, Esteve J, Bazarbachi A, Brissot E, Bug G, Ciceri F, Giebel S, Gilleece MH, Gorin NC, Lanza F, Peric Z, Ruggeri A, Sanz J, Savani BN, Schmid C, Shouval R, Spyridonidis A, Versluis J, Mohty M. Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT. Bone Marrow Transplant. 2021 Jan;56(1):218-224. doi: 10.1038/s41409-020-01005-y. Epub 2020 Jul 28.
- Schmid C, Kuball J, Bug G. Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies. J Clin Oncol. 2021 Feb 10;39(5):397-418. doi: 10.1200/JCO.20.01719. Epub 2021 Jan 12.
- Löhr P, Schiele S, Arndt TT, Grützner S, Claus R, Römmele C, Müller G, Schmid C, Dennehy KM, Rank A. Impact of age and gender on lymphocyte subset counts in patients with COVID-19. Cytometry A. 2021 Jun 14:10.1002/cyto.a.24470. doi: 10.1002/cyto.a.24470. Epub ahead of print.
- Weissinger EM, Metzger J, Schleuning M, Schmid C, Messinger D, Beutel G, Wagner-Drouet EM, Schetelig J, Baurmann H, Rank A, Stolzl F, Schäfer-Eckart K, Westphal K, Bethge W, von Harsdorf S, Bunjes DW, Heidenreich D, Klein S, Holler E, Kreipe HH, Jonigk D, Türüchanow I, Raad J, Papkalla A, von der Leyen H, Hambach L, Hamwi I, Ehrlich S, Krauter J, Stadler M, Ganser A. A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy. Leukemia. 2021 Jun;35(6):1763-1772. doi: 10.1038/s41375-020-01059-3. Epub 2020 Oct 20.
- Waidhauser J, Labopin M, Esteve J, Kröger N, Cornelissen J, Gedde-Dahl T, Van Gorkom G, Finke J, Rovira M, Schaap N, Petersen E, Beelen D, Bunjes D, Savani B, Schmid C, Nagler A, Mohty M; Acute Leukemia Working Party of EBMT. Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT. Bone Marrow Transplant. 2021 Oct;56(10):2445-2453. doi: 10.1038/s41409-021-01322-w. Epub 2021 May 31.
- Schrempf MC, Pinto DRM, Gutschon J, Schmid C, Hoffmann M, Geissler B, Wolf S, Sommer F, Anthuber M. Intraoperative endoluminal pyloromyotomy as a novel approach to reduce delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy-a retrospective study. Langenbecks Arch Surg. 2021 Jun;406(4):1103-1110. doi: 10.1007/s00423-020-02008-5. Epub 2020 Oct 14.
- A-K. Schmaelter, J. Waidhauser, D. Kaiser, T. Lenskaja, S. Gruetzner, R. Claus, M. Trepel, C. Schmid and A. Rank. Alterations of Peripheral Blood T Cell Subsets following Donor Lymphocyte Infusion in Patients after Allogeneic Stem cell Transplantation. Hemato 2021, 2, 692-702. https:/ /doi.org/10.3390/hemato2040046
- Bazarbachi A, Schmid C, Labopin M, Beelen D, Wolfgang Blau I, Potter V, Niittyvuopio R, Socié G, Blaise D, Sanz J, Ciceri F, Abou Dalle I, Spyridonidis A, Bug G, Esteve J, Savani BN, Nagler A, Mohty M.Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years. Clin Cancer Res. 2020 Dec 15;26(24):6475-6482. doi: 10.1158/1078-0432.CCR-20-3134. Epub 2020 Sep 28.
- Ralf Huss Christoph Schmid Mael Manesse Jeppe Thagaard Bruno Maerkl Immunological tumor heterogeneity and diagnostic profilingfor advanced and immune therapies AdvCellGeneTher.2021;4:e.1131 of 9https://doi.org/10.1002/acg2.
- Rank A, Peczynski C, Labopin M, Stelljes M, Simand C, Helbig G, Finke J, Santarone S, Tischer J, Lange A, Mistrik M, Houhou M, Schmid C, Nagler A, Mohty M: Feasibility and outcomes of a third allogeneic hematopoietic stem cell transplantation: a retrospective analysis from the ALWP of the EBMT Transplantation and Cellular Therapy (former Biology of Blood and Marrow Transplantation”) 2021, in press *corresponding author
- Christoph Schmid “A step closer to GvL without GvHD”, Blood 2021, in press
- Andreas Rank, Phillip Löhr, Reinhard Hoffmann, Alanna Ebigbo, Stefanie Grützner, Christoph Schmid* and Rainer Claus*: Sustained cellular immunity in adults recovered from mild COVID-19; Cytometry Part A 2021, in press *equal contribution
- Klaus Hirschbühl, Myriam Labopin, Mohamed Houhou, Ludovic Gabellier, helene labussiere, Bruno Lioure, Dietrich Beelen, Jan Cornelissen, Gerald Wulf, Pavel Jindra, Herve Tilly, Jakob Passweg, Riitta Niittyvuopio, Gesine Bug, Christoph Schmid*, Arnon Nagler, Sebastian Giebel, and Mohamad Mohty Second and third generation tyrosine kinase inhibitors for Philadelphia positive adult Acute Lymphoblastic Leukemia relapsing post allogeneic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party" Bone Marrow Transplantation 2021, in press *corresponding author
- Ali Bazarbachi*, Christoph Schmid*, Myriam Labopin, Dietrich Beelen, Igor Wolfgang Blau, Victoria Potter, Riitta Niittyvuopi, Gerard Socié, Didier Blaise, Jaime Sanz, Fabio Ciceri, Iman Abou Dalle, Alexandros Spyridonidis, Gesine Bug, Jordi Esteve, Bipin N Savani, Arnon Nagler, Mohamad Mohty “Evaluation of Trends and Prognosis Over Time in AML Relapsing After Allogeneic Hematopoeitic Cell Transplant: Improved Survival for Young Patients in Recent Years Clinical Ccancer Reseacrh 2020, in press * equal contribution
- Christoph Schmid, Juergen H.E. Kubal, Gesine Bug; „Defining the Role of Donor Lymphocyte Infusion in High Risk Hematological Malignancies”, Journal of Clinical Oncology 2020 (in press)
- Kolb HJ, Schmid C; “The FLAMSA concept-past and future”. Ann Hematol. 2020 Jun 27. doi: 10.1007/s00277-020-04131-1. Online ahead of print
- Development and validation of a disease risk stratification system for patients with haematological malignancies: a European Society for Blood and Marrow Transplantation registry retrospective cohort study Roni Shouval,, MD, Joshua A Fein, MD, Myriam Labopin, MD, Christina Cho, MD, Ali Bazarbachi, MD, Frédéric Baron, MD, Gesine Bug MD, Fabio Ciceri, MD, Selim Corbacioglu, MD, Jacques-Emmanuel Galimard, PhD, Sebastian Giebel, MD, Maria H Gilleece, MD, Sergio Giralt MD, Ann Jakubowski MD, Silvia Montoto, MD, Richard J. O'Reilly, MD, Esperanza B. Papadopoulos, MD, Zinaida Peric, MD, Annalisa Ruggeri, MD, Jaime Sanz, MD, Craig S. Sauter, MD, Bipin N. Savani, MD, Christoph Schmid, MD, Alexandros Spyridonidis, MD, Roni Tamari, MD, Jurjen Versluis, MD, Ibrahim Yakoub-Agha, MD, Miguel Angel Perales, MD, Mohamad Mohty, MD, Arnon Nagler, MD Lancet Hematology 2020, in press
- Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group Esther Schuler, Eva-Maria Wagner-Drouet, Salem Ajib, Gesine Bug, Martina Crysandt, Sabine Dressler, Andreas Hausmann, Daniela Heidenreich, Klaus Hirschbühl , Matthias Hoepting, Edgar Jost, Jennifer Kaivers, Stefan Klein, Michael Koldehoff, Lambros Kordelas, Oliver Kriege, Lutz P. Müller, Christina Rautenberg, Judith Schaffrath, Christoph Schmid, Daniel Wolff, Rainer Haas, Martin Bornhäuser, Thomas Schroeder, and Guido Kobbe On behalf of the German Cooperative Transplant Study Group Annals of Hematology 2020 (in press)
- Eva Weissinger, Jochen Metzger, Michael Schleuning, Christoph Schmid, Diethelm Messinger, Gernot Beutel, Eva Wagner, Johannes Schetelig, Herrad Baurmann, Andreas Rank, Friedrich Stolzl, Kerstin Schäfer-Eckart, Karin Westphal, Wolfgang Bethge, Stephanie von Harsdorf, Donald Bunjes, Daniela Heidenreich, Stefan Klein, Ernst Holler, Hans Kreipe, Danny Jonigk, Irina Türüchanow, Julia Raad, Armin Papkalla, Heiko von der Leyen, Lothar Hambach, Iyas Hamwi, Steve Ehrlich, Jurgen Krauter, M STADLER, and Arnold Ganser "A multicenter prospective, randomized, placebo-controlled Phase II/III trial for pre-emptive acute graft-versus-host disease therapy" Leukemia 2020, in press
- Matthias C. Schrempf, David R.M. Pinto,, Johanna Gutschon, Christoph Schmid, Michael Hoffmann, Bernd Geissler, Sebastian Wolf, Florian Sommer, and Matthias Anthuber, “Intraoperative endoluminal pyloromyotomy as a novel approach to reduce delayed gastric emptying after pylorus preserving pancreaticoduodenectomy – a retrospective study” Langenbecks Archive of Surgery 2020, in press
- Bhagirathbhai Dholaria, Myriam Labopin, Emanuele Angelucci, Fabio Ciceri, Jose L. Diez‐Martin, Benedetto Bruno, Simona Sica, Yener Koc Zafer Gülbas, Christoph Schmid, Didier Blaise, Angelo Michele Carella Guiseppe Visani, Bipin N. Savani, Arnon Nagler, Mohamad Mohty; “Impact of total body irradiation‐ vs chemotherapy‐based myeloablative conditioninon outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia” American Journal of Hematology,First published: 13 July 2020;
- Arnon Nagler, Frédéric Baron, Myriam Labopin, Emmanuelle Polge, Jordi Esteve, Ali Bazarbachi, Eolia Brissot, Gesine Bug, Fabio Ciceri, Sebastian Giebel, Maria Gilleece, Norbert Gorin, Francesco Lanza, Zinaida Peric, Annalisa Ruggeri, Jaime Sanz, Bipin Savani, Christoph Schmid, Roni Shouval, Alexandros Spyridonidis, Jurjen Versluis, and Mohamad Mohty; “Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: A survey on behalf of the ALWP of the EBMT" Bone Marrow Transplant, 2020, online ahead of print
- Burchert A, Bug G, Fritz LV, Finke J, Stelljes M, Röllig C, Wollmer E, Wäsch R, Bornhäuser M, Berg T, Lang F, Ehninger G, Serve H, Zeiser R, Wagner EM, Kröger N, Wolschke C, Schleuning M, Götze KS, Schmid C, Crysandt M, Eßeling E, Wolf D, Wang Y, Böhm A, Thiede C, Haferlach T, Michel C, Bethge W, Wündisch T, Brandts C, Harnisch S, Wittenberg M, Hoeffkes HG, Rospleszcz S, Burchardt A, Neubauer A, Brugger M, Strauch K, Schade-Brittinger C, Metzelder SK. Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN). J Clin Oncol. 2020 Sep 10;38(26):2993-3002. doi: 10.1200/JCO.19.03345. Epub 2020 Jul 16. PMID: 32673171
- Dholaria B, Labopin M, Angelucci E, Ciceri F, Diez-Martin JL, Bruno B, Sica S, Koc Y, Gülbas Z, Schmid C, Blaise D, Carella AM, Visani G, Savani BN, Nagler A, Mohty M. Impact of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning on Outcomes of Haploidentical Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia. Am J Hematol. 2020 Jul 13. doi: 10.1002/ajh.25934. Online ahead of print
- Brissot E, Labopin M, Baron F, Bazarbachi A, Bug G, Ciceri F, Esteve J, Giebel S, Gilleece MH, Gorin NC, Lanza F, Peric Z, Ruggeri A, Sanz J, Savani BN, Schmid C, Shouval R, Spyridonidis A, Versluis J, Nagler A, Mohty M. Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2020 Jun 11:1-4. doi: 10.1038/s41409-020-0970-x. online ahead of print
- Ali Bazarbachi, Gesine Bug, Frederic Baron, Eolia Brissot, Fabio Ciceri, Iman Abou Dalle, Hartmut Döhner, Jordi Esteve, Yngvar Floisand, Sebastian Giebel, Maria Gilleece, Norbert-Claude Gorin, Elias Jabbour, Mahmoud Aljurf, Hagop Kantarjian, Mohamed Kharfan Dabaja, Myriam Labopin, Francesco Lanza, Florent Malard, Zinaida Peric, Thomas Prebet, Farhad Ravandi, Annalisa Ruggeri, Jaimie Sanz, Christoph Schmid, Roni Shouval, Alexandros Spyridonidis, Jurjen Versluis, Norbert Vey, Bipin N. Savani, Arnon Nagler, and Mohamad Mohty Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3 internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, Haematologica 2020, 2020 Jun;105(6):1507-1516. doi: 10.3324/haematol.2019.243410
- Brissot E, Labopin M, Russo D, Martin S, Schmid C, Glass B, Ram R, Ozkurt ZN, Passweg J, Veelken JH, Bunjes D, Apperley J, Giebel S, Mohty M, Nagler A. Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party. Bone Marrow Transplant. 2020 Mar 17. doi: 10.1038/s41409-020-0849-x. Online ahead of print
- Spyridonidis A, Labopin M, Savani BN, Niittyvuopio R, Blaise D, Craddock C, Socié G, Platzbecker U, Beelen D, Milpied N, Cornelissen JJ, Ganser A, Huynh A, Griskevicius L, Giebel S, Aljurf M, Brissot E, Malard F, Esteve J, Peric Z, Baron F, Ruggeri A, Schmid C, Gilleece M, Gorin NC, Lanza F, Shouval R, Versluis J, Bug G, Fløisand Y, Ciceri F, Sanz J, Bazarbachi A, Nagler A, Mohty M. “Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients.” Bone Marrow Transplant. 2020 Jun;55(6):1114-1125. doi: 10.1038/s41409-020-0803-y
- Ann-Kristin Schmaelter, Myriam Labopin, Gérard Socié, Maija Itälä-Remes, Didier Blaise, Ibrahim Yakoub-Agha, Edouard Forcade, Jan Cornelissen, Arnold Ganser, Dietrich Beelen, Helene Labussiere-Wallet, Jakob Passweg, Bipin Savani, Christoph Schmid, Arnon Nagler, and Mohamad Mohty. Inferior outcome of Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in first Complete Remission as Compared to De Novo Acute Myeloid Leukemia., Blood Cancer Journal, 2020 Mar 3;10(3):26. doi: 10.1038/s41408-020-0296-3 *corresponding author
- Ayuk F, Bornhäuser M, Stelljes M, Zabelina T, Wagner EM, Schmid C, Christopeit M, Guellstorf M, Kröger N, Bethge W. Predicted Indirectly ReCognizable HLA Epitopes (PIRCHE) Are Associated with Poorer Outcome after Single Mismatch Unrelated Donor Stem Cell Transplantation: A Study of the Cooperative Transplant Study Group (KTS) of the German Group for Bone Marrow and Stem Cell Transplantation (DAG-KBT). Transfus Med Hemother. 2019 Oct;46(5):370-375. doi: 10.1159/000502389.
- Shouval R, Fein JA, Labopin M, Bazarbachi A, Baron F, Bug G, Ciceri F, Corbacioglu S, Giebel S, Gilleece MH, Montoto S, Peric Z, Polge E, Ruggeri A, Sanz J, Savani BN, Schmid C, Spyridonidis A, Versluis J, Yakoub-Agha I, Mohty M, Nagler AThe Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell Transplantation. Blood. 2019 Nov 13;134(Supplement_1):43.
- Dholaria B, Savani BN, Labopin M, Luznik L, Ruggeri A, Mielke S, Al Malki MM, Kongtim P, Fuchs E, Huang XJ, Locatelli F, Aversa F, Castagna L, Bacigalupo A, Martelli M, Blaise D, Ben Soussan P, Arnault Y, Handgretinger R, Roy DC, O'Donnell P, Bashey A, Solomon S, Romee R, Lewalle P, Gayoso J, Maschan M, Lazarus HM, Ballen K, Giebel S, Baron F, Ciceri F, Esteve J, Gorin NC, Spyridonidis A, Schmid C, Ciurea SO, Nagler A, Mohty M. Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the acute leukemia working party of the EBMT. Haematologica. 2020 (1) 47-58 doi: 10.3324/haematol.2019.219790
- Bazarbachi A, Boumendil A, Finel H, Castagna L, Dominietto A, Blaise D, Diez-Martin JL, Tischer J, Gülbas Z, Wallet HL, Corral LL, Mohty M, Koc Y, Yakoub-Agha I, Schmid C, El Cheikh J, Arat M, Forcade E, Dreger P, Rocha V, García GG, Chalandon Y, Ferra C, Orvain C, Robinson S, Montoto S, Sureda A. Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study. Br J Haematol. 2020 Mar;188(5):745-756. doi: 10.1111/bjh.16182.
- Giebel S, Boumendil A, Labopin M, Seesaghur A, Baron F, Ciceri F, Esteve J, Gorin NC, Savani B, Schmid C, Wetten S, Mohty M, Nagler A.Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Ann Hematol. 2019 Oct;98(10):2389-2398. doi: 10.1007/s00277-019-03771-2. Epub 2019 Aug 7
- Merle M, Fischbacher D, Liepert A, Grabrucker C, Kroell T, Kremser A, Dreyssig J, Freudenreich M, Schuster F, Borkhardt A, Kraemer D, Koehne CH, Kolb HJ, Schmid C, Schmetzer HM. Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the Disease. Immunol Invest. 2019 Sep 19:1-21. doi: 10.1080/08820139.2019.1661429. [Epub ahead of print].
- Amberger DC, Doraneh-Gard F, Gunsilius C, Weinmann M, Möbius S, Kugler C, Rogers N, Böck C, Ködel U, Werner JO, Krämer D, Eiz-Vesper B, Rank A, Schmid C, Schmetzer HM PGE1-Containing Protocols Generate Mature (Leukemia-Derived) Dendritic Cells Directly from Leukemic Whole Blood.Int J Mol Sci. 2019 Sep 17;20(18). pii: E4590. doi: 10.3390/ijms20184590
- Piemontese S, Boumendil A, Labopin M, Schmid C, Ciceri F, Arcese W, Koc Y, Gulbas Z, Tischer J, Bruno B, Wu D, Blaise D, Beelen D, Irrera G, Ruggeri A, Houhou M, Mohty M, Nagler A; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT. J Hematol Oncol. 2019 Jul 4;12(1):68. doi: 10.1186/s13045-019-0751-4.
- Hirn Lopez A, Deen D, Fischer Z, Rabe A, Ansprenger C, Stein K, Vogt V, Schick J, Kroell T, Kraemer D, Kolb HJ, Tischer J, Schmid C, Schmetzer H Role of Interferon (IFN)α in "Cocktails" for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic Reactions. J Immunother. 2019 Jun;42(5):143-161
- Schmid, C, Labopin, M, Schaap N, Veelken, H, Schleuning, M, Stadler, M, Finke, J, Hurst, E, Baron, F., Ringden, O, Bug, G, Blaise, D, Tischer, J, Bloor, A, Esteve, J, Giebel, S, Savani, B, Gorin, N-C, Ciceri, F, Mohty, M and Nagler A on behalf of the EBMT Acute Leukemia Working Party Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukemia – a matched pair analysis by the Acute Leukemia Working Party of EBMT British Journal of Haematology, 2019 Mar;184(5):782-787. doi: 10.1111/bjh.15691.
- Dreger P, Sureda A, Ahn KW, Eapen M, Litovich C, Finel H, Boumendil A, Gopal A, Herrera AF, Schmid C, Diez-Martin JL, Fuchs E, Bolaños-Meade J, Gooptu M, Al Malki MM, Castagna L, Ciurea SO, Dominietto A, Blaise D, Ciceri F, Tischer J, Corradini P, Montoto S, Robinson S, Gülbas Z, Hamadani M. PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL. Blood Adv. 2019 Feb 12;3(3):360-369.
- Zeiser R, Beelen DW, Bethge W, Bornhäuser M, Bug G, Burchert A, Christopeit M, Duyster J, Finke J, Gerbitz A, Klusmann JH, Kobbe G, Lübbert M, Müller-Tidow C, Platzbecker U, Rösler W, Sauer M, Schmid C, Schroeder T, Stelljes M, Kröger N, Müller LP. Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation.Biol Blood Marrow Transplant. 2019 Apr;25(4):e128-e140. doi: 10.1016/j.bbmt.2019.01.016.
- Maximilian Doppelhammer, Alessia Fraccaroli, Dusan Prevalsek, Veit Bücklein Sarah Häbe,Christoph Schulz, Max Hubmann, Andreas Hausmann, Rainer Claus Andreas Rank, Christoph Schmid*, and Johanna Tischer* (*: shared final authorship). Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning—a matched pair analysis. Ann. Haematol. 2019 Mar;98(3):753-762
- Fraccaroli A, Prevalsek D, Fritsch S, Haebe S, Bücklein V, Schulz C, Hubmann M, Stemmler HJ, Ledderose G, Hausmann A, Schmid C, Tischer J. Sequential HLA-haploidentical transplantation utilizing post-transplantation cyclophosphamide for GvHD prophylaxis in high-risk and relapsed/refractory AML/MDS. Am J Hematol. 2018 Dec;93(12):1524-1531. doi: 10.1002/ajh.25281. Epub 2018 Oct 2.
- Salyka Sengsayadeth, Katie S. Gatwood, Ariane Boumendil, Myriam Labopin, Jürgen Finke, Arnold Ganser, Matthias Stelljes, Gerhard Ehninger, Dietrich Beelen, Dietger Niederwieser, Didier Blaise, Peter Dreger, Ghulam Mufti, Patrice Chevallier, Audrey Mailhol, Maria H. Gilleece, Norbert Gorin, Jordi Esteve, Fabio Ciceri, Frederic Baron, Christoph Schmid, Sebastian Giebel, Mohamad Mohty, Bipin N. Savani, Arnon Nagler. Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study. Blood Adv. 2018 Aug 28; 2(16): 2127–2135. Published online 2018 Aug 24. doi: 10.1182/bloodadvances.2018019976
- Giebel S, Marks DI, Boissel N, Baron F, Chiaretti S, Ciceri F, Cornelissen JJ, Doubek M, Esteve J, Fielding A, Foa R, Gorin NC, Gökbuget N, Hallböök H, Hoelzer D, Paravichnikova E, Ribera JM, Savani B, Rijneveld AW, Schmid C, Wartiovaara-Kautto U, Mohty M, Nagler A, Dombret H.Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2018 Nov 1. doi: 10.1038/s41409-018-0373-4. [Epub ahead of print] Review.
- Jordan F, Grundmann N, Schenkirsch G, Märkl B, Messmann H, Anthuber M, Schmid C, Trepel M. Impact of Primary Tumor Localization on the Efficacy of Bevacizumab in Metastatic Colorectal Cancer Anticancer Res. 2018 Sep;38(9):5539-5546. doi: 10.21873/anticanres.12889
- Lee CJ, Savani BN, Mohty M, Gorin NC, Labopin M, Ruggeri A, Schmid C, Baron F, Esteve J, Giebel S, Ciceri F, Nagler A. Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2018 Aug 13. doi: 10.1038/s41409-018-0286-2. [Epub ahead of print]
- Sengsayadeth S, Labopin M, Boumendil A, Finke J, Ganser A, Stelljes M, Ehninger G, Beelen D, Niederwieser D, Blaise D, Dreger P, Mufti G, Chevallier P, Mailhol A, Gatwood KS, Gorin N, Esteve J, Ciceri F, Baron F, Schmid C, Giebel S, Mohty M, Savani BN, Nagler A. Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study. Biol Blood Marrow Transplant. 2018 Apr 17. pii: S1083-8791(18)30189-7. doi: 10.1016/j.bbmt.2018.04.008. [Epub ahead of print]
- Craddock C, Versluis J, Labopin M, Socie G, Huynh A, Deconinck E, Volin L, Milpied N, Bourhis JH, Rambaldi A, Chevallier P, Blaise D, Manz M, Vellenga E, Vekemans MC, Maertens J, Passweg J, Vyas P, Schmid C, Löwenberg B, Ossenkoppele G, Mohty M, Cornelissen JJ, Nagler A; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and HOVON-SAKK. Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia. J Intern Med. 2018 Apr;283(4):371-379. doi: 10.1111/joim.12720. Epub 2018 Jan 5.
- Heinicke T, Labopin M, Schmid C, Polge E, Socié G, Blaise D, Mufti GJ, Huynh A, Brecht A, Ledoux MP, Cahn JY, Milpied N, Scheid C, Hicheri Y, Mohty M, Savani BN, Nagler A. Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2018 Biol Blood Marrow Transplant. 2018 Nov;24(11):2224-2232
- Kharfan-Dabaja MA, Labopin M, Polge E, Nishihori T, Bazarbachi A, Finke J, Stadler M, Ehninger G, Lioure B, Schaap N, Afanasyev B, Yeshurun M, Isaksson C, Maertens J, Chalandon Y, Schmid C, Nagler A, Mohty M. Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse. JAMA Oncol. 2018 Sep 1;4(9):1245-1253. doi: 10.1001/jamaoncol.2018.2091.PMID: 30003233
- Ayuk F, Beelen DW, Bornhäuser M, Stelljes M, Zabelina T, Finke J, Kobbe G, Wolff D, Wagner EM, Christopeit M, Schmid C, Ottinger H, Groth C, Faul C, Bertz H, Rachlis E, Wolschke C, Schetelig J, Horn PA, Mytilineos J, Guellstorf M, Kelsch R, Fleischhauer K, Kröger N, Bethge W. Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome. Biol Blood Marrow Transplant. 2018 Jul 24. pii: S1083-8791(18)30365-3. doi: 10.1016/j.bbmt.2018.06.026. [Epub ahead of print]
- Ringdén O, Labopin M, Sadeghi B, Mailhol A, Beelen D, Fløisand Y, Ghavamzadeh A, Finke J, Ehninger G, Volin L, Socié G, Kröger N, Stuhler G, Ganser A, Schmid C, Giebel S, Mohty M, Nagler A What is the outcome in patients with acute leukaemia who survive severe acute graft-versus host disease? J Intern Med. 2018 Feb;283(2):166-177. doi: 10.1111/joim.12695.
- Mathew NR, Baumgartner F, Braun L, O'Sullivan D, Thomas S, Waterhouse M, Müller TA, Hanke K, Taromi S, Apostolova P, Illert AL, Melchinger W, Duquesne S, Schmitt-Graeff A, Osswald L, Yan KL, Weber A, Tugues S, Spath S, Pfeifer D, Follo M, Claus R, Lübbert M, Rummelt C, Bertz H, Wäsch R, Haag J, Schmidts A, Schultheiss M, Bettinger D, Thimme R, Ullrich E, Tanriver Y, Vuong GL, Arnold R, Hemmati P, Wolf D, Ditschkowski M Jilg C, Wilhelm K, Leiber C, Gerull S, Halter J, Lengerke C, Pabst T, Schroeder T, Kobbe G, Rösler W, Doostkam S, Meckel S, Stabla K, Metzelder SK, Halbach S, Brummer T, Hu Z, Dengjel J, Hackanson B, Schmid C, Holtick U, Scheid C Spyridonidis A, Stölzel F, Ordemann R, Müller LP, Sicre-de-Fontbrune F, Ihorst G, Kuball J, Ehlert JE, Feger D, Wagner EM, Cahn JY, Schnell J, Kuchenbauer F, Bunjes D, Chakraverty R, Richardson S, Gill S, Kröger N, Ayuk F, Vago L, Ciceri F, Müller AM, Kondo T, Teshima T, Klaeger S, Kuster B, Kim DDH, Weisdorf D, van der Velden W, Dörfel D, Bethge W, Hilgendorf I, Hochhaus A, Andrieux G, Börries M, Busch H, Magenau J, Reddy P, Labopin M, Antin JH, Henden AS, Hill GR, Kennedy GA, Bar M, Sarma A McLornan D, Mufti G, Oran B, Rezvani K, Sha O, Negrin RS, Nagler A, Prinz M, Burchert A, Neubauer A, Beelen D, Mackensen A, von Bubnoff N, Herr W, Becher B, Socié G, Caligiuri MA, Ruggiero E, Bonini C, Häcker G, Duyster J, Finke J, Pearce E, Blazar BR, Zeiser R. “Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells”. Nature Medicine. 2018 Feb 12. doi: 10.1038/nm.4484. [Epub ahead of print]
- Schmid C, de Wreede LC, van Biezen A, Finke J, Ehninger G, Ganser A, Volin L, Niederwieser D, Beelen D, Alessandrino P, Kanz L, Schleuning M, Passweg J, Veelken H, Maertens J, Cornelissen JJ, Blaise D, Gramatzki M, Milpied N, Yakub-Agha I, Mufti G, Rovira M, Arnold R, De Witte T, Robin M, Kröger N., Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia after allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of European Society of Blood and Marrow Transplantation. Haematologica. 2018 Feb;103(2):237-245. doi: 10.3324/haematol.2017.168716
- Ringdén O, Labopin M, Sadeghi B, Mailhol A, Beelen D, Fløisand Y, Ghavamzadeh A, Finke J, Ehninger G, Volin L, Socié G, Kröger N, Stuhler G, Ganser A, Schmid C, Giebel S, Mohty M, Nagler A What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease? J Intern Med. 2018 Feb;283(2):166-177. doi: 10.1111/joim.12695.
- Pohlen M, Thoennissen NH, Braess J, Thudium J, Schmid C, Kochanek M, Kreuzer KA, Lebiedz P, Görlich D, Gerth HU, Rohde C, Kessler T, Müller-Tidow C, Stelljes M, Hullerman C, Büchner T, Schlimok G, Hallek M, Waltenberger J, Hiddemann W, Berdel WE, Heilmeier B, Krug U.Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction.PLoS One. 2018 Jan 2;13(1):e0190802
- Ringdén O, Labopin M, Sadeghi B, Mailhol A, Beelen D, Fløisand Y, Ghavamzadeh A, Finke J, Ehninger G, Volin L, Socié G, Kröger N, Stuhler G, Ganser A, Schmid C, Giebel S, Mohty M, Nagler A What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease? J Intern Med. 2018 Feb;283(2):166-177. doi: 10.1111/joim.12695.
- Munker R, Labopin M, Esteve J, Schmid C, Mohty M, Nagler A.Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMT. Haematologica. 2017 Dec;102(12):2134-2140. doi: 10.3324/haematol.2017.174441.
- Craddock C, Versluis J, Labopin M, Socie G, Huynh A, Deconinck E, Volin L, Milpied N, Bourhis JH, Rambaldi A, Chevallier P, Blaise D, Manz M, Vellenga E, Vekemans MC, Maertens J, Passweg J, Vyas P, Schmid C, Löwenberg B, Ossenkoppele G, Mohty M, Cornelissen JJ, Nagler A; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and HOVON-SAKK, Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia.J Intern Med. 2017 Dec 7. doi: 10.1111/joim.12720. [Epub ahead of print]
- Schmid C, de Wreede LC, van Biezen A, Finke J, Ehninger G, Ganser A, Volin L, Niederwieser D, Beelen D, Alessandrino P, Kanz L, Schleuning M, Passweg J, Veelken H, Maertens J, Cornelissen JJ, Blaise D, Gramatzki M, Milpied N, Yakub-Agha I, Mufti G, Rovira M, Arnold R, De Witte T, Robin M, Kröger N., Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia after allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of European Society of Blood and Marrow Transplantation. Haematologica. 2017 Nov 3. pii: haematol.2017.168716. doi: 10.3324/haematol.2017.168716. [Epub ahead o
- Lee CJ, Savani BN, Mohty M, Labopin M, Ruggeri A, Schmid C, Baron F, Esteve J, Gorin NC, Giebel S, Ciceri F, Nagler A Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica. 2017 Nov;102(11):1810-1822. doi: 10.3324/haematol.2017.176107. Epub 2017 Sep 7.
- Brissot E, Labopin M, Stelljes M, Ehninger G, Schwerdtfeger R, Finke J, Kolb HJ, Ganser A, Schäfer-Eckart K, Zander AR, Bunjes D, Mielke S, Bethge WA, Milpied N, Kalhs P, Blau IW, Kröger N, Vitek A, Gramatzki M, Holler E, Schmid C, Esteve J, Mohty M, Nagler A. Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT. J Hematol Oncol. 2017 Jun 24;10(1):130. doi: 10.1186/s13045-017-0498-8.
- Dickinson AM, Norden J, Li S, Hromadnikova I, Schmid C, Schmetzer H, Jochem-Kolb H.Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia. Front Immunol. 2017 Jun 7;8:496. doi: 10.3389/fimmu.2017.00496.
Canaani J, Savani BN, Labopin M, Michallet M, Craddock C, Socié G, Volin L, Maertens JA, Crawley C, Blaise D, Ljungman PT, Cornelissen J, Russell N, Baron F, Gorin N, Esteve J, Ciceri F, Schmid C, Giebel S, Mohty M, Nagler A. ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT. Am J Hematol. 2017 Aug;92(8):789-796. doi: 10.1002/ajh.24771. Epub 2017 Jun 9 - Ringdén O, Labopin M, Schmid C, Sadeghi B, Polge E, Tischer J, Ganser A, Michallet M, Kanz L, Schwerdtfeger R, Nagler A, Mohty M; Acute Leukaemia Working Party of the EBMT.Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT. Br J Haematol. 2017 Feb;176(3):431-439. doi: 10.1111/bjh.14428. Epub 2016 Nov 23.
- Baron F, Mohty M, Blaise D, Socié G, Labopin M, Esteve J, Ciceri F, Giebel S, Gorin NC, Savani BN, Schmid C, Nagler A. „Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.” Haematologica. 2017; 102(2):224-234
- Malard F, Labopin M, Stuhler G, Bittenbring J, Ganser A, Tischer J, Michallet M, Kröger N, Schmid C, Huynh A, Hallek M, Savani BN, Mohty M, Nagler A. „Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation”. Biol Blood Marrow Transplant. 2017 Feb;23(2):278-284
- Baron F, Mohty M, Blaise D, Socié G, Labopin M, Esteve J, Ciceri F, Giebel S, Gorin NC, Savani BN, Schmid C, Nagler A. „Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.” Haematologica. 2016 Dec 7. pii: haematol.2016.148510. [Epub ahead of print]
- Ringdén O, Labopin M, Schmid C, Sadeghi B, Polge E, Tischer J, Ganser A, Michallet M, Kanz L, Schwerdtfeger R, Nagler A, Mohty M; Acute Leukaemia Working Party of the EBMT. „Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT”. Br J Haematol. 2016 Nov 23. doi: 10.1111/bjh.14428. [Epub ahead of print]
- Malard F, Labopin M, Stuhler G, Bittenbring J, Ganser A, Tischer J, Michallet M, Kröger N, Schmid C, Huynh A, Hallek M, Savani BN, Mohty M, Nagler A. „Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation”. Biol Blood Marrow Transplant. 2016 Nov 2. pii: S1083-8791(16)30460-8. doi: 10.1016/j.bbmt.2016.11.002. [Epub ahead of print]
- Tsirigotis P, Byrne M, Schmid C, Baron F, Ciceri F, Esteve J, Gorin NC, Giebel S, Mohty M, Savani BN, Nagler A. „Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT”. Bone Marrow Transplant. 2016 Nov;51(11):1431-1438. doi: 10.1038/bmt.2016.167.
- Baron F, Ruggeri A, Beohou E, Labopin M, Sanz G, Milpied N, Michallet M, Bacigalupo A, Blaise D, Sierra J, Socié G, Cornelissen JJ, Schmid C, Giebel S, Gorin NC, Esteve J, Ciceri F, Savani BN, Mohty M, Gluckman E, Nagler A. “RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT.“ Oncotarget. 2016 May 26. doi: 10.18632/oncotarget.9599. [Epub ahead of print]
- Giebel S, Czyz A, Ottmann O, Baron F, Brissot E, Ciceri F, Cornelissen JJ, Esteve J, Gorin NC, Savani B, Schmid C, Mohty M, Nagler A. „Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.“ Cancer. 2016 Oct;122(19):2941-51
- Pohlen M, Thoennissen NH, Braess J, Thudium J, Schmid C, Kochanek M, Kreuzer KA, Lebiedz P, Görlich D, Gerth HU, Rohde C, Kessler T, Müller-Tidow C, Stelljes M, Büchner T, Schlimok G, Hallek M, Waltenberger J, Hiddemann W, Berdel WE, Heilmeier B, Krug U. „Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction.” PLoS One. 2016 Aug 30;11(8):e0160871.
- Baron F, Ruggeri A, Beohou E, Labopin M, Sanz G, Milpied N, Michallet M, Bacigalupo A, Blaise D, Sierra J, Socié G, Cornelissen JJ, Schmid C, Giebel S, Gorin NC, Esteve J, Ciceri F, Savani BN, Mohty M, Gluckman E, Nagler A. „RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT.“ Oncotarget. 2016 Jul12;7(28):43027-43038